228 related articles for article (PubMed ID: 32687633)
1. Zonal regulation of collagen-type proteins and posttranslational modifications in prostatic benign and cancer tissues by imaging mass spectrometry.
Angel PM; Spruill L; Jefferson M; Bethard JR; Ball LE; Hughes-Halbert C; Drake RR
Prostate; 2020 Sep; 80(13):1071-1086. PubMed ID: 32687633
[TBL] [Abstract][Full Text] [Related]
2. Extracellular matrix alterations in low-grade lung adenocarcinoma compared with normal lung tissue by imaging mass spectrometry.
Angel PM; Bruner E; Bethard J; Clift CL; Ball L; Drake RR; Feghali-Bostwick C
J Mass Spectrom; 2020 Apr; 55(4):e4450. PubMed ID: 31654589
[TBL] [Abstract][Full Text] [Related]
3. Proteomic profiling of breast tissue collagens and site-specific characterization of hydroxyproline residues of collagen alpha-1-(I).
Montgomery H; Rustogi N; Hadjisavvas A; Tanaka K; Kyriacou K; Sutton CW
J Proteome Res; 2012 Dec; 11(12):5890-902. PubMed ID: 23110299
[TBL] [Abstract][Full Text] [Related]
4. MALDI-MS tissue imaging identification of biliverdin reductase B overexpression in prostate cancer.
Pallua JD; Schaefer G; Seifarth C; Becker M; Meding S; Rauser S; Walch A; Handler M; Netzer M; Popovscaia M; Osl M; Baumgartner C; Lindner H; Kremser L; Sarg B; Bartsch G; Huck CW; Bonn GK; Klocker H
J Proteomics; 2013 Oct; 91():500-14. PubMed ID: 23954705
[TBL] [Abstract][Full Text] [Related]
5. Identification of clinically relevant protein targets in prostate cancer with 2D-DIGE coupled mass spectrometry and systems biology network platform.
Ummanni R; Mundt F; Pospisil H; Venz S; Scharf C; Barett C; Fälth M; Köllermann J; Walther R; Schlomm T; Sauter G; Bokemeyer C; Sültmann H; Schuppert A; Brümmendorf TH; Balabanov S
PLoS One; 2011 Feb; 6(2):e16833. PubMed ID: 21347291
[TBL] [Abstract][Full Text] [Related]
6. The Proteome of Primary Prostate Cancer.
Iglesias-Gato D; Wikström P; Tyanova S; Lavallee C; Thysell E; Carlsson J; Hägglöf C; Cox J; Andrén O; Stattin P; Egevad L; Widmark A; Bjartell A; Collins CC; Bergh A; Geiger T; Mann M; Flores-Morales A
Eur Urol; 2016 May; 69(5):942-52. PubMed ID: 26651926
[TBL] [Abstract][Full Text] [Related]
7. Profiling protein markers associated with lymph node metastasis in prostate cancer by DIGE-based proteomics analysis.
Pang J; Liu WP; Liu XP; Li LY; Fang YQ; Sun QP; Liu SJ; Li MT; Su ZL; Gao X
J Proteome Res; 2010 Jan; 9(1):216-26. PubMed ID: 19894759
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity in proline hydroxylation of fibrillar collagens observed by mass spectrometry.
Kirchner M; Deng H; Xu Y
PLoS One; 2021; 16(8):e0250544. PubMed ID: 34464391
[TBL] [Abstract][Full Text] [Related]
9. Imaging mass spectrometry of a specific fragment of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 2 discriminates cancer from uninvolved prostate tissue.
Cazares LH; Troyer D; Mendrinos S; Lance RA; Nyalwidhe JO; Beydoun HA; Clements MA; Drake RR; Semmes OJ
Clin Cancer Res; 2009 Sep; 15(17):5541-51. PubMed ID: 19690195
[TBL] [Abstract][Full Text] [Related]
10. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
11. Normal, benign, preneoplastic, and malignant prostate cells have distinct protein expression profiles resolved by surface enhanced laser desorption/ionization mass spectrometry.
Cazares LH; Adam BL; Ward MD; Nasim S; Schellhammer PF; Semmes OJ; Wright GL
Clin Cancer Res; 2002 Aug; 8(8):2541-52. PubMed ID: 12171882
[TBL] [Abstract][Full Text] [Related]
12. Differentiating tumor heterogeneity in formalin-fixed paraffin-embedded (FFPE) prostate adenocarcinoma tissues using principal component analysis of matrix-assisted laser desorption/ionization imaging mass spectral data.
Panderi I; Yakirevich E; Papagerakis S; Noble L; Lombardo K; Pantazatos D
Rapid Commun Mass Spectrom; 2017 Jan; 31(2):160-170. PubMed ID: 27791282
[TBL] [Abstract][Full Text] [Related]
13. Discovery of serum protein biomarkers for prostate cancer progression by proteomic analysis.
Al-Ruwaili JA; Larkin SE; Zeidan BA; Taylor MG; Adra CN; Aukim-Hastie CL; Townsend PA
Cancer Genomics Proteomics; 2010; 7(2):93-103. PubMed ID: 20335524
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive Characterization of Glycosylation and Hydroxylation of Basement Membrane Collagen IV by High-Resolution Mass Spectrometry.
Basak T; Vega-Montoto L; Zimmerman LJ; Tabb DL; Hudson BG; Vanacore RM
J Proteome Res; 2016 Jan; 15(1):245-58. PubMed ID: 26593852
[TBL] [Abstract][Full Text] [Related]
15. Prohibitin identified by proteomic analysis of prostate biopsies distinguishes hyperplasia and cancer.
Ummanni R; Junker H; Zimmermann U; Venz S; Teller S; Giebel J; Scharf C; Woenckhaus C; Dombrowski F; Walther R
Cancer Lett; 2008 Aug; 266(2):171-85. PubMed ID: 18384941
[TBL] [Abstract][Full Text] [Related]
16. Collagen I and III and metalloproteinase gene and protein expression in prostate cancer in relation to Gleason score.
Duarte AH; Colli S; Alves-Pereira JL; Martins MP; Sampaio FJ; Ramos CF
Int Braz J Urol; 2012; 38(3):341-54; discussion 354-5. PubMed ID: 22765866
[TBL] [Abstract][Full Text] [Related]
17. Mapping Extracellular Matrix Proteins in Formalin-Fixed, Paraffin-Embedded Tissues by MALDI Imaging Mass Spectrometry.
Angel PM; Comte-Walters S; Ball LE; Talbot K; Mehta A; Brockbank KGM; Drake RR
J Proteome Res; 2018 Jan; 17(1):635-646. PubMed ID: 29161047
[TBL] [Abstract][Full Text] [Related]
18. Unfavorable prognostic value of human PEDF decreased in high-grade prostatic intraepithelial neoplasia: a differential proteomics approach.
Qingyi Z; Lin Y; Junhong W; Jian S; Weizhou H; Long M; Zeyu S; Xiaojian G
Cancer Invest; 2009 Aug; 27(7):794-801. PubMed ID: 19637042
[TBL] [Abstract][Full Text] [Related]
19. Prostate cancer diagnosis and characterization with mass spectrometry imaging.
Kurreck A; Vandergrift LA; Fuss TL; Habbel P; Agar NYR; Cheng LL
Prostate Cancer Prostatic Dis; 2018 Sep; 21(3):297-305. PubMed ID: 29209003
[TBL] [Abstract][Full Text] [Related]
20. MMP-12 catalytic domain recognizes and cleaves at multiple sites in human skin collagen type I and type III.
Taddese S; Jung MC; Ihling C; Heinz A; Neubert RH; Schmelzer CE
Biochim Biophys Acta; 2010 Apr; 1804(4):731-9. PubMed ID: 19932771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
